HDAC2 as a new target to improve schizophrenia treatment

Expert Rev Neurother. 2013 Jan;13(1):1-3. doi: 10.1586/ern.12.141.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antipsychotic Agents / therapeutic use
  • Enzyme Inhibitors / therapeutic use
  • Histone Deacetylase 2 / metabolism*
  • Humans
  • Schizophrenia / drug therapy
  • Schizophrenia / enzymology*

Substances

  • Antipsychotic Agents
  • Enzyme Inhibitors
  • Histone Deacetylase 2